Atenolol contraindications: Difference between revisions

Jump to navigation Jump to search
ShiSheng (talk | contribs)
No edit summary
 
Gerald Chi (talk | contribs)
mNo edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Atenolol}}
{{Atenolol}}
Line 9: Line 8:


TENORMIN is contraindicated in those patients with a history of [[hypersensitivity]] to the atenolol or any of the drug product’s components.<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = TENORMIN (ATENOLOL) TABLET [ASTRAZENECA PHARMACEUTICALS LP] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fcfc9676-4edc-460e-6199-8161b824908f | publisher =  | date =  | accessdate = 5 February 2014 }}</ref>
TENORMIN is contraindicated in those patients with a history of [[hypersensitivity]] to the atenolol or any of the drug product’s components.<ref name="dailymed.nlm.nih.gov">{{Cite web  | last =  | first =  | title = TENORMIN (ATENOLOL) TABLET [ASTRAZENECA PHARMACEUTICALS LP] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=fcfc9676-4edc-460e-6199-8161b824908f | publisher =  | date =  | accessdate = 5 February 2014 }}</ref>


==References==
==References==
Line 20: Line 14:


[[Category:Beta blockers]]
[[Category:Beta blockers]]
[[Category:Cardiovascular Drugs]]
[[Category:Cardiovascular Drugs]]
[[Category:Drugs]]
[[Category:Drugs]]
{{WikiDoc Help Menu}}
{{WikiDoc Help Menu}}
{{WikiDoc Sources}}
{{WikiDoc Sources}}
rugs]]

Revision as of 02:32, 10 February 2014

Atenolol
TENORMIN ® FDA Package Insert
Indications and Usage
Dosage and Administration
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
How Supplied/Storage and Handling
Labels and Packages
Clinical Trials on Atenolol
ClinicalTrials.gov

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sheng Shi, M.D. [2]

Contraindications

TENORMIN is contraindicated in sinus bradycardia, heart block greater than first degree, cardiogenic shock, and overt cardiac failure. (See WARNINGS.)

TENORMIN is contraindicated in those patients with a history of hypersensitivity to the atenolol or any of the drug product’s components.[1]

References

  1. "TENORMIN (ATENOLOL) TABLET [ASTRAZENECA PHARMACEUTICALS LP]". Retrieved 5 February 2014.


Template:WikiDoc Sources